- Home
- MLYS vs INV Comparison
MLYS vs INV Comparison
Compare MLYS & INV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- INV
- Stock Information
- Founded
- MLYS 2019
- INV 2015
- Country
- MLYS United States
- INV United States
- Employees
- MLYS N/A
- INV N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- INV
- Sector
- MLYS Health Care
- INV
- Exchange
- MLYS Nasdaq
- INV NYSE
- Market Cap
- MLYS 1.0B
- INV 173.3M
- IPO Year
- MLYS 2023
- INV N/A
- Fundamental
- Price
- MLYS $14.54
- INV $4.93
- Analyst Decision
- MLYS Strong Buy
- INV Strong Buy
- Analyst Count
- MLYS 4
- INV 2
- Target Price
- MLYS $27.00
- INV $14.00
- AVG Volume (30 Days)
- MLYS 862.9K
- INV 184.1K
- Earning Date
- MLYS 08-12-2025
- INV 08-15-2025
- Dividend Yield
- MLYS N/A
- INV N/A
- EPS Growth
- MLYS N/A
- INV N/A
- EPS
- MLYS N/A
- INV N/A
- Revenue
- MLYS N/A
- INV $1,220,000.00
- Revenue This Year
- MLYS N/A
- INV $1,045.66
- Revenue Next Year
- MLYS N/A
- INV $240.46
- P/E Ratio
- MLYS N/A
- INV N/A
- Revenue Growth
- MLYS N/A
- INV 18.27
- 52 Week Low
- MLYS $8.24
- INV $3.00
- 52 Week High
- MLYS $18.38
- INV $18.75
- Technical
- Relative Strength Index (RSI)
- MLYS 47.97
- INV N/A
- Support Level
- MLYS $13.22
- INV N/A
- Resistance Level
- MLYS $14.54
- INV N/A
- Average True Range (ATR)
- MLYS 0.71
- INV 0.00
- MACD
- MLYS 0.00
- INV 0.00
- Stochastic Oscillator
- MLYS 68.37
- INV 0.00
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About INV INNVENTURE INC
Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.